arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2013 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    New US cholesterol guideline: a paradigmatic change?

    NEW ON THE MARKET

    Teriflunomide (AUBAGIO) against multiple sclerosis

    THERAPY FROM A CRITICAL VIEWPOINT

    Preference of live attenuated influenza vaccine in 2 to 6 year old children?

    HPV-based cervical cancer screening

    a-t READERS' QUESTIONS AND COMMENTS

    Hydroxyethyl starch against sudden hearing loss?

    Breast cancer with the progestogen-containing intrauterine device MIRENA

    IN BRIEF

    Heavily advertised and often bought - irrational fixed combinations against common cold

    Restriction of use of hydroxyethyl starch instead of withdrawal from the market
    free

    Calcium-free phosphate binders in patients with renal insufficiency

    Market research with brain scans

    CURRENT ADR NETWORK REPORT

    Liver damage with rivaroxaban (XARELTO)

    SIDE EFFECTS

    Haemophagocytic syndrome with the multiple sclerosis drug fingolimod (GILENYA)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles